Madrigal Pharmaceuticals inc. buy BiotechBee
Start price
19.01.25
/
70%
€305.00
Target price
30.11.27
€380.00
Performance (%)
4.39%
End price
23.02.25
€318.40
Summary
This prediction ended on 23.02.25 with a price of €318.40. With a performance of 4.39%, the BUY prediction by BiotechBee for Madrigal Pharmaceuticals inc. closed with a slight gain. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Madrigal Pharmaceuticals inc. | -1.816% | -1.816% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Madrigal Pharmaceuticals inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Buy mit Kursziel 380,0
In the thread Trading Madrigal Pharmaceuticals inc.
Stopped prediction by BiotechBee for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€318.40
23.02.25
23.02.25
€400.00
31.12.26
31.12.26
49.47%
21.11.25
21.11.25
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€214.90
24.06.23
24.06.23
€380.00
31.05.26
31.05.26
33.50%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€66.50
30.09.22
30.09.22
€120.00
31.12.24
31.12.24
324.36%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year